AE Wealth Management LLC Sells 6,708 Shares of Kimberly-Clark Co. (NYSE:KMB)

AE Wealth Management LLC reduced its stake in Kimberly-Clark Co. (NYSE:KMB) by 3.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 166,693 shares of the company’s stock after selling 6,708 shares during the period. AE Wealth Management LLC’s holdings in Kimberly-Clark were worth $23,037,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Rise Advisors LLC increased its holdings in shares of Kimberly-Clark by 926.3% in the 1st quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after buying an additional 176 shares during the last quarter. Crewe Advisors LLC bought a new stake in shares of Kimberly-Clark in the 1st quarter worth about $27,000. New Millennium Group LLC bought a new stake in shares of Kimberly-Clark in the 2nd quarter worth about $28,000. Strategic Financial Concepts LLC bought a new stake in shares of Kimberly-Clark in the 2nd quarter worth about $32,000. Finally, Fortitude Family Office LLC increased its holdings in shares of Kimberly-Clark by 333.3% in the 2nd quarter. Fortitude Family Office LLC now owns 325 shares of the company’s stock worth $45,000 after buying an additional 250 shares during the last quarter. 76.29% of the stock is currently owned by institutional investors.

Kimberly-Clark Trading Down 0.7 %

NYSE KMB opened at $140.10 on Friday. The company has a fifty day simple moving average of $142.31 and a two-hundred day simple moving average of $135.89. The stock has a market cap of $47.17 billion, a P/E ratio of 25.75, a P/E/G ratio of 3.04 and a beta of 0.39. Kimberly-Clark Co. has a 12-month low of $116.32 and a 12-month high of $149.30. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59.

Kimberly-Clark (NYSE:KMB) last issued its earnings results on Tuesday, July 23rd. The company reported $1.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.25. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The firm had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $5.10 billion. During the same quarter last year, the company posted $1.65 earnings per share. The firm’s revenue was down 2.0% compared to the same quarter last year. On average, analysts forecast that Kimberly-Clark Co. will post 7.25 earnings per share for the current year.

Kimberly-Clark Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 2nd. Investors of record on Friday, September 6th will be given a dividend of $1.22 per share. The ex-dividend date is Friday, September 6th. This represents a $4.88 annualized dividend and a yield of 3.48%. Kimberly-Clark’s dividend payout ratio is presently 89.71%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $165.00 price target on shares of Kimberly-Clark in a research note on Wednesday, July 24th. Piper Sandler boosted their price target on shares of Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a report on Thursday, July 11th. BNP Paribas began coverage on shares of Kimberly-Clark in a report on Monday, June 24th. They issued a “neutral” rating and a $146.00 price target for the company. TD Cowen began coverage on shares of Kimberly-Clark in a report on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 price target for the company. Finally, Wells Fargo & Company reduced their price target on shares of Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating for the company in a report on Wednesday, July 24th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Kimberly-Clark presently has a consensus rating of “Hold” and an average target price of $145.67.

Insider Activity at Kimberly-Clark

In related news, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the sale, the insider now owns 19,935 shares in the company, valued at $2,819,207.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, insider Gonzalo Uribe sold 1,780 shares of Kimberly-Clark stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the sale, the insider now owns 7,377 shares in the company, valued at $1,038,976.68. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey P. Melucci sold 37,699 shares of Kimberly-Clark stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares in the company, valued at approximately $2,819,207.70. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.